To the Editor: Dr Pradhan and colleagues1 found that elevated levels of interleukin 6 (IL-6)
were associated with the risk of developing type 2 diabetes mellitus in a
large cohort of apparently healthy middle-aged women. Their data are consistent
with the results of others.2,3
According to Pradhan et al, type 2 diabetes mellitus may be a manifestation
of a long lasting and ongoing cytokine-mediated acute phase response involving
IL-6. However, the mechanisms of the diabetogenic action of IL-6 are far from
clear. Modulation of insulin secretion by IL-6 does not seem to be a major
factor; on the other hand, there is recent evidence that IL-6 may produce
insulin resistance.2,3 Cytokines
can exert their effects either directly or indirectly, although a direct effect
of IL-6 on the insulin–receptor transduction pathway has not been demonstrated.
Indirect effects on insulin resistance have been attributed to the stimulatory
action of IL-6 on the hypothalamic-pituitary-adrenal axis, hence to induction
of a hypercortisolemic state.3 In fact,
hypercortisolism leads to insulin resistance in a number of conditions.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 5
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.